Common use of Purchase Price; Number of Shares Clause in Contracts

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 (the “Purchase Price”), 185,714 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). (b) On the Commitment Termination Date, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 4% of the Aggregate Advances under the Loan Agreement, if any, by (B) the Purchase Price In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “"Holder”"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.73 (the “"Purchase Price”"), 185,714 up to a maximum of 300,578 fully paid and nonassessable shares of the Company’s 's Series D Preferred Stock, (the “Exercise Quantity”), $0.001 per share par value (the “"Preferred Stock”"). Commencing on the date hereof, 150,289 (the "Exercise Quantity") of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Date, or such earlier termination of this Warrant in accordance with the terms hereof, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 43.25% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price, rounded down to the nearest whole number. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 4.00 (the “Purchase Price”), 185,714 100,000 fully paid and nonassessable shares of the Company’s Series D E Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). (b) On the Commitment Termination Date, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D E Preferred Stock, if any, as is equal to the amount determined by dividing (A) 48% of the Aggregate Advances under the Loan Agreement, if any, by (B) the Purchase Price In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”)Warrant, commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.80 (the “Purchase Price”), 185,714 250,000 (before giving effect to a six-for-one reverse stock split of the Company’s Preferred Stock to be effected in October 2007) fully paid and nonassessable shares of the Company’s Series D E Preferred Stock, Stock (the “Exercise Quantity”), $0.001 par value Quantity (the “Preferred Stock”). (b) On the Commitment Termination Date, the The Exercise Quantity shall automatically be increased increase by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is an amount equal to the amount determined by dividing (A) 45% of the Aggregate Advances under Commitment Two of the Loan Agreement, if any, Agreement divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.58 (the “Purchase Price”), 185,714 up to a maximum of 517,242 fully paid and nonassessable shares of the Company’s Series D B Convertible Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). Commencing on the date hereof, 258,621 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Date, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 43% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.00 (the “Purchase Price”), 185,714 up to a maximum of 200,000 fully paid and nonassessable shares of the Company’s Series D A Preferred Stock, (the “Exercise Quantity”), $0.001 0.0001 par value (the “Preferred Stock”). Commencing on the date hereof, 100,000 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination DateDate or such earlier termination of this Warrant in accordance with the terms hereof, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 42% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.72 (the “Purchase Price”), 185,714 up to a maximum of 52,325 fully paid and nonassessable shares of the Company’s Series D A-l Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 34,883 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination DateDate or such earlier termination of this Warrant in accordance with the terms hereof, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 42% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 4.80446 (the “Purchase Price”), 185,714 up to a maximum of 499,535 fully paid and nonassessable shares of the Company’s Series D E Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). Commencing on the date hereof, 333,023 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Funding Date, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 44.0% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 5.0497 (the “Purchase Price”), 185,714 up to a maximum of 237,638 fully paid and nonassessable shares of the Company’s Series D C Preferred Stock, (the “Exercise Quantity”), $0.001 0.00001 par value (the “Preferred Stock”). Commencing on the date hereof, 89,114 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Date, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole sharenumber) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 45% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.83 (the “Purchase Price”), 185,714 up to a maximum of 963,856 fully paid and nonassessable non-assessable shares of the Company’s Series D Convertible Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 421,687 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Date, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 44.5% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 0.9304 (the “Purchase Price”), 185,714 up to a maximum of 271,221 fully paid and nonassessable shares of the Company’s Series D B Preferred Stock, (the “Exercise Quantity”), $0.001 par value (the “Preferred Stock”). Commencing on the date hereof, 110,000 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Date, or such earlier termination of this Warrant in accordance with the terms hereof, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded down to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 43% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price, up to a maximum of 271,221 shares of Preferred Stock, including the Exercise Quantity. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.75 (the “Purchase Price”), 185,714 up to a maximum of 15,000 fully paid and nonassessable shares of the Company’s Series D A-3 Preferred Stock, (the “Exercise Quantity”), $0.001 0.01 par value (the “Preferred Stock”). Commencing on the date hereof, 8,571 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination DateDate or such earlier termination of this Warrant in accordance with the terms hereof, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 41.5% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “Holder”), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 5.2581 (the “Purchase Price”), 185,714 up to a maximum of 228,219 fully paid and nonassessable shares of the Company’s Series D Preferred Stock, (the “Exercise Quantity”), $0.001 0.00001 par value (the “Preferred Stock”). Commencing on the date hereof, 114,109 (the “Exercise Quantity”) of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Date, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole sharenumber) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 4% of the amount of Aggregate Advances funded under the Loan Agreement, if any, divided by (B) the Purchase Price Price. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “"Holder”"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.125 (the “"Purchase Price”"), 185,714 up to a maximum of 933,333 fully paid and nonassessable shares of the Company’s 's Series D B Preferred Stock, Stock (the “Exercise Quantity”"Shares"), $0.001 par value (the “"Preferred Stock”").. Commencing on the date hereof, 533,333 (the "Exercise Quantity") of shares of Preferred Stock are immediately available for purchase hereunder (b) On the Commitment Termination DateDate for Commitment Three, the Exercise Quantity shall automatically be increased by (i) such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 43% of the Aggregate Advances under the Loan Agreement, if any, divided by (B) the Purchase Price Price. For purposes of clarification, the maximum number of Shares that the Exercise Quantity may be increased by is 400,000. In addition to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:

Purchase Price; Number of Shares. (a) The registered holder of this Warrant (the “"Holder”"), commencing on the date hereof, is entitled upon surrender of this Warrant with the subscription form annexed hereto duly executed, at the principal office of the Company, to purchase from the Company, at a price per share of $2.80 1.73 (the “"Purchase Price”"), 185,714 up to a maximum of 485,548 fully paid and nonassessable shares of the Company’s 's Series D Preferred Stock, (the “Exercise Quantity”), $0.001 per share par value (the “"Preferred Stock”"). Commencing on the date hereof, 323,699 (the "Exercise Quantity") of shares of Preferred Stock are immediately available for purchase hereunder. (b) On the Commitment Termination Dateearlier of January 1, 2009 or an automatic net exercise of the Warrant in connection with a Merger pursuant to Section 7, the Exercise Quantity shall automatically be increased by such additional number of shares (rounded to the nearest whole share) of Series D Preferred Stock, if any, as is equal to the amount determined by dividing (A) 44.00% of the Aggregate Advances amount of outstanding principal balance under Notes funded under Commitment Two of that certain Loan and Security Agreement No. 5251 dated June 30, 2006 between the Company and Lighthouse Capital Partners V, L.P., (the "Loan Agreement") as amended, if any, divided by (B) the Purchase Price In addition Price, rounded down to other terms which may be defined herein, the following terms, as used in this Warrant, shall have the following meanings:nearest whole number.